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We collected acute-phase serum samples from febrile
patients at 2 major hospitals in Dhaka, Bangladesh, during
an outbreak of dengue fever in 2001. A total of 18% of
dengue-negative patients tested positive for leptospirosis.
The case-fatality rate among leptospirosis patients (5%)
was higher than among dengue fever patients (1.2%).
L
eptospirosis is a zoonotic infection caused by spiro-
chetes of the genus Leptospira. Infection usually
results when water or soil contaminated with the urine of
an infected animal comes in contact with human skin or
mucous membranes (1). Clinical manifestations of lep-
tospirosis can range from a self-limited febrile syndrome
to a fatal illness (Weil disease) characterized by hemor-
rhage, renal failure, and jaundice. In tropical settings, lep-
tospirosis can be indistinguishable from other febrile
illnesses such as scrub typhus, malaria, or dengue.
Although leptospirosis has been reported in neighbor-
ing areas of Southeast Asia (2,3), the disease is not recog-
nized in Bangladesh, where diagnostic tests for
leptospirosis are not available. However, environmental
factors, such as floods, humidity, and water contamination,
are amenable to spread of the disease in Bangladesh.
An epidemic of dengue fever and dengue hemorrhagic
fever began in Bangladesh in 2000 (4), and a surveillance
system was established to identify patients with dengue-
like illness at 2 major hospitals in Dhaka. Approximately
three-quarters of patients meeting surveillance criteria had
laboratory evidence of dengue infection. We hypothesized
that leptospirosis might be a cause of illness among febrile
patients who did not have dengue fever. To assess this, we
retrospectively analyzed acute-phase serum samples from
all dengue-negative patients by using real-time polymerase
chain reaction (PCR) for Leptospira. We used data collect-
ed as part of the surveillance program to identify distin-
guishing clinical characteristics of leptospirosis. 
The Study
In 2000, the International Centre for Diarrhoeal Disease
Research, Bangladesh (ICDDR,B) worked with staff from
Dhaka Medical College and Holy Family Red Crescent
Hospital to initiate surveillance for dengue as part of an
emergency response to an epidemic of dengue and dengue
hemorrhagic fever. Physicians at Dhaka Medical College
and Holy Family Red Crescent Hospital were trained in the
clinical diagnosis and management of dengue and dengue
hemorrhagic fever according to World Health
Organization guidelines. Patients hospitalized with fever
and in whom a physician suspected dengue were enrolled
in the surveillance program. Clinical and epidemiologic
information, as well as acute-phase serum specimens, were
systematically collected from surveillance patients. Acute-
phase serum specimens were assessed for dengue virus
antibodies by using a commercial immunoglobulin (Ig)G
and IgM capture enzyme-linked immunosorbent assay
(ELISA) (PanBio Dengue Duo, PanBio Ltd., Brisbane,
Queensland, Australia) (5). In addition, serum samples col-
lected from a subset of patients during the first 5 days of
illness were evaluated for dengue virus RNA by using
reverse transcriptase–polymerase chain reaction (RT-
PCR), as described previously (6). Serum samples from
patients with no dengue infection shown by antibody or
RT-PCR testing were retrospectively assessed for lep-
tospirosis by using a real-time PCR that amplifies the
LipL32 gene (7), a virulence factor that is conserved
among pathogenic Leptospira strains (8). Microplate
Leptospira IgM ELISA testing (PanBio Ltd) was conduct-
ed on all Leptospira PCR-positive serum specimens of suf-
ficient quantity (9). 
Specimens from 1,297 patients hospitalized at Dhaka
Medical College and Holy Family Red Crescent Hospital
between January 1 and December 31, 2001, were evaluat-
ed for dengue infection by using capture ELISA; 55 acute-
phase serum samples were additionally evaluated by using
RT-PCR for dengue. A total of 938 (72%) patients were
diagnosed with dengue fever by serology (932 patients),
RT-PCR (3 patients), or both (3 patients). Acute-phase
serum specimens from the 359 patients without laboratory
evidence of dengue were evaluated for leptospirosis; 63
(18%) had Leptospira detected by using PCR. Sixty-one of
the PCR-positive samples were tested for Leptospira-spe-
cific IgM; 18 (30%) showed positive results and 5 (8%)
showed equivocal results. 
Patients with leptospirosis diagnosed by using PCR
were 6 to 70 years of age (mean 28, SD 13); 74% were
DENGUE DISPATCHES
766 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 5, May 2005
*Massachusetts General Hospital, Boston, Massachusetts, USA;
†International Centre for Diarrhoeal Disease Research,
Bangladesh, Dhaka, Bangladesh; ‡Centers for Disease Control
and Prevention, Atlanta, Georgia, USA; §Dhaka Medical College
Hospital, Dhaka, Bangladesh; and ¶Centers for Disease Control
and Prevention, San Juan, Puerto Rico, USAmale. Patients with leptospirosis were of similar age and
sex as patients with dengue (Table 1). Patients with lep-
tospirosis had less education and came from households
with lower income than patients with dengue. The peak
occurrence of leptospirosis was in October and November,
shortly after the monsoon season in Bangladesh. This
overlapped with the period of highest dengue activity (July
through December) (Figure).
Patients with leptospirosis reported a slightly longer
duration of fever than patients with dengue (Table 2).
While most patients with dengue or leptospirosis had con-
tinuous fever, an intermittent fever was more likely with
leptospirosis. Reports of rash were more common with
dengue fever. Aside from fever and rash, the symptoms of
patients with leptospirosis and dengue were similar (Table
2): headache, myalgia, nausea, and vomiting were most
common.
The median temperature and heart rate at physical
examination were higher in leptospirosis patients than in
dengue patients. Evidence of bleeding, including petechial
rash, positive tourniquet test result, and gum bleeding,
were more common in patients with dengue, although they
were also found in some patients with leptospirosis.
Subconjunctival hemorrhage, which may have been con-
fused with conjunctival inflammation, was more common-
ly reported in patients with leptospirosis. Hepatomegaly
and jaundice were more common in leptospirosis patients,
but this difference was not statistically significant.
On laboratory examination, total leukocyte counts were
similar in patients with dengue and patients with lep-
tospirosis; however, lymphocytes were more likely to be
predominant in patients with dengue. Hemoconcentration
and thrombocytopenia were associated with dengue fever.
Of the patients whose outcome was known, 3 (5%)
patients with leptospirosis died, compared with 11 (1.2%)
patients with dengue (p = 0.048). Antimicrobial therapy
for leptospirosis was not provided, and data on the cause of
death were not available. The patients who died of lep-
tospirosis were younger than those who died of dengue (24
± 6 years of age vs. 36 ± 9 years, p = 0.05).
Conclusions
This is the first description of disease caused by
Leptospira in urban Bangladesh. Our findings indicate that
leptospirosis causes serious febrile illness in the densely
populated city of Dhaka.
Studies conducted in other dengue-endemic areas have
shown that leptospirosis can be confused with dengue
fever (10–12). Most clinical symptoms of leptospirosis
patients in Dhaka were nonspecific and not distinguishable
from symptoms associated with dengue fever or other viral
illnesses. Although fever in leptospirosis patients was
higher and of longer duration than in dengue patients, there
is sufficient overlap of clinical findings to suggest that cli-
nicians caring for patients in Bangladesh should maintain
a high index of suspicion for both diseases, especially dur-
ing the peak incidence seasons that follow the monsoons.
Leptospirosis during Dengue Outbreak, Bangladesh
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 5, May 2005 767
Figure. Proportion of dengue and leptospirosis patients at 2 major
hospitals in Dhaka, Bangladesh, by month, 2001. Recognition of leptospirosis is especially important since
antimicrobial agents can reduce its severity and duration
(13).
Leptospirosis patients identified in Dhaka were impov-
erished and poorly educated. This may reflect more fre-
quent exposure to environments contaminated with urine
from rodents or other animals. In contrast, dengue patients
came from households with higher incomes and levels of
education. Whether these socioeconomic differences
reflect differing patterns of disease can only be determined
by future population-based studies, which may in turn shed
light on optimal prevention strategies. 
Most of the patients hospitalized with leptospirosis and
dengue virus infection in Dhaka during the period of this
study were male. A recent seroprevalence study in
Bangladesh did not demonstrate a sex difference in
dengue seropositivity (14), but leptospirosis has been
reported predominantly in men in other regions (15).
Further prospective research would be useful to better
define the clinical spectrum and gender distribution of
disease in Bangladesh.
This study has a number of limitations. Only acute-
phase serum samples were obtained as part of the hospital-
based dengue surveillance program in Bangladesh.
Serologic diagnosis of leptospirosis with a single specimen
obtained early in infection is limited; hence, we used
Leptospira-specific PCR for diagnosis in our study popu-
lation. Although this molecular technique is highly sensi-
tive and specific for the presence of leptospiremia (7),
more cases may have been detected through the use of
microscopic agglutination testing on paired serum sam-
ples. Notably, less than one-third of the patients with a
diagnosis of leptospirosis by PCR had detectable levels of
Leptospira-specific IgM. This is likely due to the sampling
of acutely ill patients before seroconversion. In support of
this, leptospirosis patients who had detectable levels of
IgM exhibited a trend toward longer duration of fever
compared with those who did not have detectable levels
(6.5 vs. 5.5 days, p = 0.12).
Some cases of leptospirosis resulted in death, and the
case-fatality rate among leptospirosis patients was signifi-
cantly higher than among dengue fever patients. The dif-
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intensive training in dengue case management that
occurred during this epidemic period, or to the lack of spe-
cific antimicrobial therapy for unrecognized cases of lep-
tospirosis. Our findings underscore the need for greater
awareness of leptospirosis in the Indian subcontinent,
more data on its incidence in Bangladesh, and optimal
treatment regimens for leptospirosis that can be applied in
resource-poor settings. 
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